The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Altered Cell Adhesion and Glycosylation Promote Cancer Immune Suppression and Metastasis
Open accessAbstract
Cell-cell interactions and cell adhesion are key mediators of cancer progression and facilitate hallmarks of cancer including immune evasion and metastatic dissemination. Many cell adhesion molecules within the tumor microenvironment are changed and significant alterations of glycosylation are observed. These changes in cell adhesion molecules alter the ability of tumor cells to interact with other cells and extracellular matrix proteins. Three families of cell-cell interaction molecules selectins, Siglecs, and integrins have been associated with cancer progression in many pre-clinical studies, yet inhibition of cell adhesion as a therapeutic target is just beginning to be explored. We review how cell-cell interactions mediated by integrins and the glycan-binding receptors selectins and Siglec receptors support cancer progression. The discussion focuses on mechanisms during immune evasion and metastasis that can be therapeutically targeted by blocking these cell-cell interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcium's Role in Mechanotransduction during Muscle Development
Benavides Damm, T., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,502
Integrins: Versatility, modulation, and signaling in cell adhesion
Hynes, R. O. (1992) · Cell · doi:10.1016/0092-8674(92)90115-s · Cited by 9,859
Tumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101
Wiederschain, G. Y. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909090156 · Cited by 4,083
Tumour-associated macrophages as treatment targets in oncology
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.217 · Cited by 4,033
Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2748 · Cited by 3,736
Glycosylation in cancer: mechanisms and clinical implications
Pinho, S. S., & Reis, C. A. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3982 · Cited by 3,083
Siglecs and their roles in the immune system
Crocker, P. R., Paulson, J. C., & Varki, A. (2007) · Nature Reviews Immunology · doi:10.1038/nri2056 · Cited by 2,031
Labelle, M., Begum, S., & Hynes, R. O. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.009 · Cited by 1,833
Mucins in cancer: protection and control of the cell surface
Hollingsworth, M. A., & Swanson, B. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1251 · Cited by 1,807
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Barkal, A. A., Brewer, R. E., Markovic, M., Kowarsky, M., Barkal, S. A., Zaro, B. W., Krishnan, V., Hatakeyama, J., Dorigo, O., Barkal, L. J., et al. (2019) · Nature · doi:10.1038/s41586-019-1456-0 · Cited by 1,385
The sweet and sour of cancer: glycans as novel therapeutic targets
Fuster, M. M., & Esko, J. D. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1649 · Cited by 1,383
Interactions between cancer stem cells and their niche govern metastatic colonization
Malanchi, I., Santamaria-Martínez, A., Susanto, E., Peng, H., Lehr, H.-A., Delaloye, J.-F., & Huelsken, J. (2012) · Nature · doi:10.1038/nature10694 · Cited by 1,339
Neutrophils escort circulating tumour cells to enable cell cycle progression
Szczerba, B. M., Castro-Giner, F., Vetter, M., Krol, I., Gkountela, S., Landin, J., Scheidmann, M. C., Donato, C., Scherrer, R., Singer, J., et al. (2019) · Nature · doi:10.1038/s41586-019-0915-y · Cited by 1,225
Macrophage Regulation of Tumor Responses to Anticancer Therapies
De Palma, M., & Lewis, C. E. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.013 · Cited by 1,079
Lysis of tumor cells by natural killer cells in mice is impeded by platelets.
Nieswandt, B., Hafner, M., Echtenacher, B., & Männel, D. N. (1999) · PubMed · Cited by 977
Klebanoff, C. A., Gattinoni, L., Torabi-Parizi, P., Kerstann, K., Cardones, A. R., Finkelstein, S. E., Palmer, D. C., Antony, P. A., Hwang, S. T., Rosenberg, S. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503726102 · Cited by 969
Gattinoni, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24480 · Cited by 958
Cooper, J., & Giancotti, F. G. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.007 · Cited by 945
β1-6 Branching of Asn-Linked Oligosaccharides Is Directly Associated with Metastasis
Dennis, J. W., Laferté, S., Waghorne, C., Breitman, M. L., & Kerbel, R. S. (1987) · Science · doi:10.1126/science.2953071 · Cited by 940
Crossing the endothelial barrier during metastasis
Reymond, N., d'Água, B. B., & Ridley, A. J. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3628 · Cited by 922
Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs
Oskarsson, T., Acharyya, S., Zhang, X. H.-F., Vanharanta, S., Tavazoie, S. F., Morris, P. G., Downey, R. J., Manova-Todorova, K., Brogi, E., & Massagué, J. (2011) · Nature Medicine · doi:10.1038/nm.2379 · Cited by 869 · cited 1×
“TNC is a ligand for β1- and β3-integrin and its accumulation in the lungs promotes tumor cell outgrowth and metastasis (81).”
BackgroundBorsig, L., Wong, R., Feramisco, J., Nadeau, D. R., Varki, N. M., & Varki, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061615598 · Cited by 714
Self-citationIntegrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
Seguin, L., Desgrosellier, J. S., Weis, S. M., & Cheresh, D. A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.12.006 · Cited by 685
The role of selectins in inflammation and disease
Ley, K. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00071-6 · Cited by 682
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
Wang, J., Sun, J., Liu, L. N., Flies, D. B., Nie, X., Toki, M., Zhang, J., Song, C., Zarr, M., Zhou, X., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0374-x · Cited by 679
Integrin activation controls metastasis in human breast cancer
Felding-Habermann, B., O'Toole, T. E., Smith, J. W., Fransvea, E., Ruggeri, Z. M., Ginsberg, M. H., Hughes, P. E., Pampori, N., Shattil, S. J., Saven, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1853 · Cited by 577
Platelets guide the formation of early metastatic niches
Labelle, M., Begum, S., & Hynes, R. O. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411082111 · Cited by 555
Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins
Stupack, D. G., Puente, X. S., Boutsaboualoy, S., Storgard, C. M., & Cheresh, D. A. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200106070 · Cited by 554
Lu, X., Mu, E., Wei, Y., Riethdorf, S., Yang, Q., Yuan, M., Yan, J., Hua, Y., Tiede, B. J., Lu, X., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.002 · Cited by 492
NF-κB Mediates αvβ3 Integrin-induced Endothelial Cell Survival
Scatena, M., Almeida, M., Chaisson, M. L., Fausto, N., Nicosia, R. F., & Giachelli, C. M. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.4.1083 · Cited by 485
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
Hudak, J. E., Canham, S. M., & Bertozzi, C. R. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1388 · Cited by 485
Sialic acids in cancer biology and immunity
Pearce, O. M. T., & Läubli, H. (2016) · Glycobiology · doi:10.1093/glycob/cwv097 · Cited by 470 · cited 1×
“Terminal sialylation on N-glycans and O-glycans of glycoproteins is frequently observed in cancer (44, 59, 106).”
BackgroundSelectins promote tumor metastasis
Läubli, H., & Borsig, L. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.04.005 · Cited by 461
Self-citationP-selectin deficiency attenuates tumor growth and metastasis
Kim, Y. J., Borsig, L., Varki, N. M., & Varki, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9325 · Cited by 454
Self-citationPrecision glycocalyx editing as a strategy for cancer immunotherapy
Xiao, H., Woods, E. C., Vukojicic, P., & Bertozzi, C. R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608069113 · Cited by 440
Jandus, C., Boligan, K. F., Chijioke, O., Liu, H., Dahlhaus, M., Démoulins, T., Schneider, C., Wehrli, M., Hunger, R. E., Baerlocher, G. M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci65899 · Cited by 439
Selectins: lectins that initiate cell adhesion under flow
McEver, R. P. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00367-8 · Cited by 413
Borsig, L., Wong, R., Hynes, R. O., Varki, N. M., & Varki, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261704098 · Cited by 400
Self-citationIntravascular Survival and Extravasation of Tumor Cells
Strilic, B., & Offermanns, S. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.001 · Cited by 397
Altered Tumor-Cell Glycosylation Promotes Metastasis
Häuselmann, I., & Borsig, L. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00028 · Cited by 382
Self-citationBeatson, R., Tajadura-Ortega, V., Achkova, D., Picco, G., Tsourouktsoglou, T.-D., Klausing, S., Hillier, M., Maher, J., Noll, T., Crocker, P. R., et al. (2016) · Nature Immunology · doi:10.1038/ni.3552 · Cited by 378
An integrin β3-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition
Seguin, L., Kato, S., Franovic, A., Camargo, M. F., Lesperance, J., Elliott, K. C., Yebra, M., Mielgo, A., Lowy, A. M., Husain, H., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb2953 · Cited by 374
Shibue, T., & Weinberg, R. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904227106 · Cited by 364
Huh, S. J., Liang, S., Sharma, A., Dong, C., & Robertson, G. P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4442 · Cited by 352
Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells
Aoudjit, F., & Vuori, K. (2001) · Oncogene · doi:10.1038/sj.onc.1204554 · Cited by 325
Seales, E. C., Jurado, G. A., Brunson, B. A., Wakefield, J. K., Frost, A. R., & Bellis, S. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3117 · Cited by 317
Selectin ligands: will the real ones please stand up?
Varki, A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119142 · Cited by 315
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells
Stanczak, M. A., Siddiqui, S. S., Trefny, M. P., Thommen, D. S., Boligan, K. F., von Gunten, S., Tzankov, A., Tietze, L., Lardinois, D., Heinzelmann-Schwarz, V., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120612 · Cited by 296
Self-citationYoshimura, M., Nishikawa, A., Ihara, Y., Taniguchi, S., & Taniguchi, N. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8754 · Cited by 292
Wolf, M. J., Hoos, A., Bauer, J., Boettcher, S., Knust, M., Weber, A., Simonavicius, N., Schneider, C., Lang, M., Stürzl, M., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.023 · Cited by 290
Self-citationGlycosylation: a hallmark of cancer?
Vajaria, B. N., & Patel, P. S. (2017) · Glycoconjugate Journal · doi:10.1007/s10719-016-9755-2 · Cited by 286
Sialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cell–Mediated Tumor Immunity
Büll, C., Boltje, T. J., Balneger, N., Weischer, S. M., Wassink, M., van Gemst, J. J., Bloemendal, V. R., Boon, L., van der Vlag, J., Heise, T., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3376 · Cited by 268
Glycan Array Screening Reveals a Candidate Ligand for Siglec-8*
Bochner, B. S., Alvarez, R. A., Mehta, P., Bovin, N. V., Blixt, O., White, J. R., & Schnaar, R. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412378200 · Cited by 262
Targeting the perivascular niche sensitizes disseminated tumour cells to chemotherapy
Carlson, P., Dasgupta, A., Grzelak, C. A., Kim, J., Barrett, A., Coleman, I. M., Shor, R. E., Goddard, E. T., Dai, J., Schweitzer, E. M., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0267-0 · Cited by 251
Esposito, M., Mondal, N., Greco, T. M., Wei, Y., Spadazzi, C., Lin, S.-C., Zheng, H., Cheung, C., Magnani, J. L., Lin, S.-H., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0309-2 · Cited by 250
Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasis
Rodrigues, J. G., Balmaña, M., Macedo, J. A., Poças, J., Fernandes, Â., de-Freitas-Junior, J. C. M., Pinho, S. S., Gomes, J., Magalhães, A., Gomes, C., et al. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.03.007 · Cited by 247
Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities
Rodrigues, E., & Macauley, M. (2018) · Cancers · doi:10.3390/cancers10060207 · Cited by 240
The Role of αvβ3 in Prostate Cancer Progression
Cooper, C. R., Chay, C. H., & Pienta, K. J. (2002) · Neoplasia · doi:10.1038/sj.neo.7900224 · Cited by 238
Trikha, M., Zhao, Z., Tímár, J., Raso, E., Kennel, M., Emmell, E., & Nakada, M. T. (2002) · PubMed · Cited by 237
Inflammatory chemokines and metastasis—tracing the accessory
Borsig, L., Wolf, M. J., Roblek, M., Lorentzen, A., & Heikenwalder, M. (2014) · Oncogene · doi:10.1038/onc.2013.272 · Cited by 229
Self-citationLäubli, H., Pearce, O. M. T., Schwarz, F., Siddiqui, S. S., Deng, L., Stanczak, M. A., Deng, L., Verhagen, A., Secrest, P., Lusk, C., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409580111 · Cited by 228
Self-citationExtravasation of leukocytes in comparison to tumor cells
Strell, C., & Entschladen, F. (2008) · Cell Communication and Signaling · doi:10.1186/1478-811x-6-10 · Cited by 228
A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature
Jin, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24751 · Cited by 225
Integrin β4 signaling promotes tumor angiogenesis
Nikolopoulos, S. N., Blaikie, P., Yoshioka, T., Guo, W., & Giancotti, F. G. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.029 · Cited by 220
P-selectin is a nanotherapeutic delivery target in the tumor microenvironment
Shamay, Y., Elkabets, M., Li, H., Shah, J., Brook, S., Wang, F., Adler, K., Baut, E., Scaltriti, M., Jena, P. V., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf7374 · Cited by 220
Loss of Siglec expression on T lymphocytes during human evolution
Nguyen, D. H., Hurtado-Ziola, N., Gagneux, P., & Varki, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510484103 · Cited by 204
Glycosylation and Integrin Regulation in Cancer
Marsico, G., Russo, L., Quondamatteo, F., & Pandit, A. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2018.05.009 · Cited by 204
Negative Regulation of T Cell Receptor Signaling by Siglec-7 (p70/AIRM) and Siglec-9
Ikehara, Y., Ikehara, S. K., & Paulson, J. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403538200 · Cited by 203
Tumor cell α3β1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis
Wang, H., Fu, W., Im, J. H., Zhou, Z., Santoro, S. A., Iyer, V., DiPersio, C. M., Yu, Q.-C., Quaranta, V., Al-Mehdi, A., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200309112 · Cited by 199
Uemura, T., Shiozaki, K., Yamaguchi, K., Miyazaki, S., Satomi, S., Kato, K., Sakuraba, H., & Miyagi, T. (2009) · Oncogene · doi:10.1038/onc.2008.471 · Cited by 184
CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo
Tian, G., Courtney, A. N., Jena, B., Heczey, A., Liu, D., Marinova, E., Guo, L., Xu, X., Torikai, H., Mo, Q., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83476 · Cited by 173
Haas, Q., Boligan, K. F., Jandus, C., Schneider, C., Simillion, C., Stanczak, M. A., Haubitz, M., Jafari, S. M. S., Zippelius, A., Baerlocher, G. M., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0505 · Cited by 172
Borsig, L. (2018) · Glycobiology · doi:10.1093/glycob/cwx105 · Cited by 167
Self-citationLäubli, H., Spanaus, K.-S., & Borsig, L. (2009) · Blood · doi:10.1182/blood-2008-10-186585 · Cited by 166
Self-citationSelectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis
Gout, S., Tremblay, P., & Huot, J. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9096-4 · Cited by 162
Kannagi, R. (2003) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000033631.35357.41 · Cited by 159
Läubli, H., Stevenson, J. L., Varki, A., Varki, N. M., & Borsig, L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3121 · Cited by 158
Self-citationTargeting sialic acid–Siglec interactions to reverse immune suppression in cancer
Adams, O. J., Stanczak, M. A., von Gunten, S., & Laubli, H. P. (2017) · Glycobiology · doi:10.1093/glycob/cwx108 · Cited by 156
Leukocyte Migration Is Regulated by L-Selectin Endoproteolytic Release
Venturi, G. M., Tu, L., Kadono, T., Khan, A. I., Fujimoto, Y., Oshel, P. E., Bock, C. B., Miller, A. S., Albrecht, R. M., Kubes, P., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00295-4 · Cited by 155
Tremblay, P.-L., Auger, F. A., & Huot, J. L. (2006) · Oncogene · doi:10.1038/sj.onc.1209664 · Cited by 147
CD44 on LS174T Colon Carcinoma Cells Possesses E-Selectin Ligand Activity
Hanley, W. D., Burdick, M. M., Κωνσταντόπουλος, Κ., & Sackstein, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4557 · Cited by 135
Galkina, E., Tanousis, K. M., Preece, G., Tolaini, M., Kioussis, D., Florey, O., Haskard, D. O., Tedder, T. F., & Ager, A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030485 · Cited by 130
Laubli, H. P., Alisson‐Silva, F., Stanczak, M. A., Siddiqui, S. S., Deng, L., Verhagen, A., Varki, N. M., & Varki, A. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.593129 · Cited by 129
Viewing Siglecs through the lens of tumor immunology
Fraschilla, I. R., & Pillai, S. S. (2017) · Immunological Reviews · doi:10.1111/imr.12526 · Cited by 125
Interactions between endothelial selectins and cancer cells regulate metastasis
St. Hill Catherine, A. (2011) · Frontiers in bioscience · doi:10.2741/3909 · Cited by 123
Sun, Z., Schwenzer, A., Rupp, T., Murdamoothoo, D., Vegliante, R., Lefèbvre, O., Klein, A., Hussenet, T., & Orend, G. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1597 · Cited by 123
Gerdes, N., Seijkens, T. T. P., Lievens, D., Kuijpers, M. J. E., Winkels, H., Projahn, D., Hartwig, H., Beckers, L., Megens, R. T. A., Boon, L., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.307074 · Cited by 120
Boligan, K. F., Mesa, C., Fernandez, L. E., & von Gunten, S. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1799-5 · Cited by 119
Perdicchio, M., Cornelissen, L. A. M., Streng‐Ouwehand, I., Engels, S., Verstege, M. I., Boon, L., Geerts, D., van Kooyk, Y., & Unger, W. W. J. (2016) · Oncotarget · doi:10.18632/oncotarget.6822 · Cited by 119
PI3Kα activates integrin α4β1 to establish a metastatic niche in lymph nodes
Garmy-Susini, B. H., Avraamides, C. J., Desgrosellier, J. S., Schmid, M. C., Foubert, P., Ellies, L. G., Lowy, A. M., Blair, S. L., VandenBerg, S. R., Datnow, B., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219603110 · Cited by 99
Guo, H., Randolph, M. E., & Pierce, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611518200 · Cited by 96
Pröpster, J. M., Yang, F., Rabbani, S., Ernst, B., Allain, F. H. ‐., & Schubert, M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602214113 · Cited by 96
Uchiyama, S., Sun, J., Fukahori, K., Ando, N., Wu, M., Schwarz, F., Siddiqui, S. S., Varki, A. P., Marth, J. D., & Nizet, V. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815572116 · Cited by 96
Häuselmann, I., Roblek, M., Protsyuk, D., Huck, V., Knopfová, L., Grässle, S., Bauer, A. T., Schneider, S. W., & Borsig, L. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0784 · Cited by 90
Self-citationSelectins as Mediators of Lung Metastasis
Laubli, H. P., & Borsig, L. (2010) · Cancer Microenvironment · doi:10.1007/s12307-010-0043-6 · Cited by 88
Self-citationL-Selectin Enhanced T Cells Improve the Efficacy of Cancer Immunotherapy
Watson, H. A., Durairaj, R. R. P., Ohme, J., Alatsatianos, M., Almutairi, H., Mohammed, R. N., Vigar, M. A., Reed, S. G., Paisey, S. J., Marshall, C., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01321 · Cited by 87
Padler‐Karavani, V., Hurtado‐Ziola, N., Chang, Y., Sonnenburg, J. L., Ronagh, A., Yu, H., Verhagen, A., Nizet, V., Chen, X., Varki, N. M., et al. (2013) · The FASEB Journal · doi:10.1096/fj.13-241497 · Cited by 85
Contribution of very late antigen-4 (VLA-4) integrin to cancer progression and metastasis
Schlesinger, M., & Bendas, G. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9545-x · Cited by 73
Tenascin-C and Integrin α9 Mediate Interactions of Prostate Cancer with the Bone Microenvironment
Martin, R. S., Pathak, R. R., Jain, A., Jung, S. Y., Hilsenbeck, S. G., Piña-Barba, M. C., Sikora, A. G., Pienta, K. J., & Rowley, D. R. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0064 · Cited by 72
Selectin ligands: will the real ones please stand up?
Varki, A. P. (1997) · PubMed · Cited by 71
Role of Siglec-7 in Apoptosis in Human Platelets
Nguyen, K., Hamzeh‐Cognasse, H., Palle, S., Anselme‐Bertrand, I., Arthaud, C., Chavarin, P., Pozzetto, B., Garraud, O., & Cognasse, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106239 · Cited by 52
Hang, Q., Isaji, T., Hou, S., Zhou, Y., Fukuda, T., & Gu, J. (2016) · Scientific Reports · doi:10.1038/srep33507 · Cited by 51
Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses
Kwan, B. H., Zhu, E. F., Tzeng, A., Sugito, H. R., Eltahir, A., Ma, B., Delaney, M. K., Murphy, P. A., Kauke, M. J., Angelini, A., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160831 · Cited by 49
Liu, C., Hu, R., Huang, M.-J., Lai, I., Chen, C., Lai, H., Wu, Y., & Huang, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094995 · Cited by 47
Possible Influences of Endogenous and Exogenous Ligands on the Evolution of Human Siglecs
Angata, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02885 · Cited by 45
Roles of Integrin α6β4 Glycosylation in Cancer
Kariya, Y., Kariya, Y., & Gu, J. (2017) · Cancers · doi:10.3390/cancers9070079 · Cited by 43
β4-Integrin/PI3K Signaling Promotes Tumor Progression through the Galectin-3– N -Glycan Complex
Kariya, Y., Oyama, M., Hashimoto, Y., Gu, J., & Kariya, Y. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0365 · Cited by 43
Yuan, Y., Wu, L., Shen, S., Wu, S., & Burdick, M. M. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.071 · Cited by 42
Human-Specific Evolutionary Changes in the Biology of Siglecs
Schwarz, F., Fong, J. J., & Varki, A. P. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-11280-0_1 · Cited by 41
Metastatic Growth Progression Caused by PSGL-1–Mediated Recruitment of Monocytes to Metastatic Sites
Hoos, A., Protsyuk, D., & Borsig, L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0946 · Cited by 38
Self-citationHaas, Q., Simillion, C., & von Gunten, S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00068 · Cited by 19
Cited by
Glycosylation: mechanisms, biological functions and clinical implications
He, M., Zhou, X., & Wang, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01886-1 · Cited by 499
Altered glycosylation in cancer: A promising target for biomarkers and therapeutics
Thomas, D., Rathinavel, A. K., & Radhakrishnan, P. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188464 · Cited by 372
Insights into the role of sialylation in cancer progression and metastasis
Dobie, C., & Skropeta, D. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01126-7 · Cited by 348
Pathological implication of protein post-translational modifications in cancer
Pan, S., & Chen, R. (2022) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101097 · Cited by 263
Glycosylation in cancer: mechanisms, diagnostic markers, and therapeutic applications
Qusairy, Z., & Rada, M. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05303-1 · Cited by 16
Metadata
- Authors
- Läubli, H., & Borsig, L.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2019-09-06
- Volume
- 10
- Pages
- 2120-2120
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2969726961
- Cited by
- 282
- References
- 112
- FWCI
- 18.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.